Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer

Clinical trial NCT05360277 · RECRUITING

Trial details

NCT number: NCT05360277
Sponsor: Yanhong Deng
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer，NED

Start date: 2023-08-22
Primary completion: 2025-02-28
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.